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Thepresentpaperdemonstratestheincreasedphotostabilityofisotretinoinwhenloadedinmicroemulsion.Thephotodegradation
ofisotretinoin,inmethanolandmicroemulsionformulationwasstudiedunderdirectsunlight.Thephotodegradationprocesswas
monitored by UV spectrophotometry. In methanol solution, isotretinoin undergoes complete photodegradation just within a few
minutes of light exposure. Isotretinoin incorporated in microemulsion formulation showed an increased stability in comparison
to the methanol solutions. In particular for isotretinoin, a residual concentration of 75% was still present after a light irradiance
versus a residual value of just 16% measured at the same time in methanol solution. Further, degradation kinetic parameters of
isotretinoin-loaded microemulsion formulation were demonstrated increase isotretinoin half-life about ﬁve-times in comparison
with a methanol solution under a direct sun light.
1.Introduction
Topical retinoids constitute the core of nearly all therapeutic
programs in the mild to moderate acne with an ability to
be used to treat noninﬂammatory and inﬂammatory acne.
The therapeutic success in acne is highly dependent on a
regular application of the topical agents over a prolonged
period of time. But there are several factors which would
seemto indicate that topical application may be problematic.
Among them is the extremely low solubility of the com-
pounds, limiting incorporation into an acceptable vehicle,
photoinstability which may render topically applied drug
ineﬀective and tolerability problem leading to signiﬁcant
erythema, dryness, peeling, scaling and irritation of skin.
This results in discontinuation of treatment or compliance
problems in patients who continue treatment [1–3].
Isotretinoin (ITN), a derivative of retinoic acid (13-
cis-retinoic acid), is the most eﬀective compound with
potential to suppress acne over the long term. However,
low solubility of ITN limits its incorporation in a suitable
vehicle while its poor photostability renders the topically
applieddrugineﬀective.Therefore,thedevelopmentofnovel
formulations characterized by high photoprotection of ITN
seemstobeimportant,aswellaneﬃcientinvestigationabout
the photodegradation processes occurring in the ITN in the
developed formulations. The inclusion of the drugs in the
novel formulation matrix represents an approach of growing
interest to the problem of light-sensitive drugs [4–7].
Novel drug delivery strategies like liposomes, niosomes,
aspasomes, microsponges, microemulsion (ME), hydrogels,
& solid-lipid nanoparticles can play a pivotal role in opti-
mizing & enhancing the topical delivery of antiacne agents
by either modulating their physicochemical & biopharma-
ceutical properties or minimizing/eliminating the side eﬀects
associatedwiththem,thusoﬀeringbetterpatientcompliance
[8–10].
The interest in the development of the drug delivery
system for ITN based on ME is because they oﬀer an
interesting & potentially a quite powerful way for drug
delivery as colloidal drug carrier due to their versatility
& attractive advantages. The favourable cutaneous drug
delivery properties due to large concentration gradients
provided by large drug solubility potential of vehicle aﬃnity
for the drug together with ease of formulation, their physical2 ISRN Pharmaceutics
& thermodynamic stability makes ME a very promising
vehicles for future topical formulations. Also, topically
applied microemulsions (MEs) have been demonstrated
to signiﬁcantly increase the cutaneous absorption of both
lipophilic and hydrophilic drugs compared to conventional
vehicles for example, aqueous solutions, neat oil phases,
micellar solutions, emulsions, and liposomes [11–13].
Drugs photostability represents a signiﬁcant problem
in pharmaceutical research, several articles and reviews
dealing with diﬀerent aspects of such studies are present.
Photostability testing for new drugs is included as integral
part of stress testing in the ICH guideline [14]a n dr e a l l y
is an essential activity of the pharmaceutical industry [15].
Formulation and manufacturing process seem to be of
decisive importance for drug photostability [16] and several
approach systems have been proposed in order to enhance
stability for a number of drugs [17].
Photostability studies for retinoic acid formulations have
b e e np e r f o r m e do nl o t i o n[ 18], pharmaceuticals [19], and
cosmetics [20]. The inclusion of retinoic acid in liposomes
was reported to protect the drug against photodegradation
[21], as well as a profound characterization of retinoic
acid-liposome [22] and niosome complexes [23]h a sb e e n
described. Shah et al. evaluated the ability of solid-lipid
nanoparticle in improving the photostability of tretinoin as
compared to tretinoin in methanol and reported that encap-
sulation of tretinoin in solid-lipid nanoparticle resulted in a
signiﬁcant improvement in its photostability in comparison
to methanolic solution and also prevented its isomerization
[24]. Ioele et al. reported that tretinoin and ITN undergo
a stepwise photodegradation in ethanol with a ﬁrst very
rapid isomerization to 13-cis and 9-cis isomers, respectively,
both followed by a slower degradation to give several
isomers. Inclusion of the drugs in liposome matrix was
proved to show an improved stability to light. Also, the fast
isomerization realized in ethanol from both compounds is
avoided in liposomes. They were demonstrated to decrease
tretinoin half-life about twelve-times in comparison with an
ethanol solution, under a light power of 250W/m2. Further,
authors concluded that the inclusion of ITN in liposomes
showed a worse performance as compared to tretinoin in
liposomes, probably due to low inclusion attributable to its
nonlinear molecular structure [25].
No literature (to date) was found about the inclusion of
ITNinMEs.Hencethepresentstudywasundertakenwithan
aimtoincreasethephotostabilityofITNwhenloadedinME.
ITN-loaded matrixes were subjected to photodegradation
studies, either in solution or ME, and an interpretation of
the photodegradation process of ITN by determination of
kinetic parameters was tried as a complementary aim of the
photostability study. Analytical monitoring of the retinoic
acids was performed by UV spectrophotometry.
2.MaterialsandMethods
2.1. Apparatus. Absorbance was measured, and spectra were
recorded over the wavelength range 200–800nm in two
matched quartz cells with a 1cm light path using a double
beam Perkin Elmer Lambda 19 (Perkin Elmer, Norwalk, CT)
UV-Visible spectrophotometer.
2.2. Chemicals. ITN was procured as gratis samples from
Astron Research Ltd. (Ahmedabad, India). Analytical-grade
methanol (E. Merck, Mumbai, India) was used for the sam-
ple preparation. Isopropyl Myristate (IPM) was purchased
form National Chemicals (Vadodara, India). Caprylocaproyl
macrogol-8-glyceride and polyglyceryl oleate were procured
as gratis sample form Gattefosse (Saint-Priest, France).
Double distilled water was used for the preparation of MEs
to avoid surface active impurities.
2.3. Laboratory Precautions. To minimize drugs photodegra-
dation, all handling of ITN was carried out under red lamp
(60W)andwheneverpossibleamberizedglasswarewasused.
2.4. Preparation of Standard Stock Solutions. Stock solution
was prepared by weighing ITN pure powder (10mg),
weighed powder was accurately transferred to a volumetric
ﬂask of 100mL and dissolved in and diluted to the mark
with methanol to obtain a standard stock solution of ITN
(100µg/mL). Working standards, to obtain concentrations
within a range of 5.0–40.0µg/mL for ITN, were prepared by
appropriate dilution with methanol of the stock solutions
and used to set up the calibration curves.
2.5. Preparation of ITN-Loaded Microemulsions. In order
to ﬁnd out the concentration range of components for
the existing range of MEs, pseudoternary phase diagrams
were constructed using water titration method at ambient
temperature. Three phase diagrams were prepared with the
1:1, 2:1, and 3:1 weight ratios of caprylocaproyl macrogol-
8-glyceride to polyglyceryl oleate, respectively. For each
phase diagram at a speciﬁc surfactant (S)/cosurfactant (CoS)
mixing ratio (Km), the ratios of oil to the mixture of
S/CoS were varied as 0.5:9.5, 1:9, 1.5:8.5, 2:8, 2.5:7.5,
3:7, 3.5:6.5, 4:6, 4.5:5.5, 5:5, 5.5:4.5, 6:4, 6.5:3.5, 7:3,
7.5:2.5, 8:2, 8.5:1.5, 9:1, and 9.5:0.5. The mixtures of
oil and S/CoS at certain weight ratios were diluted with
water dropwise, under moderate magnetic stirring. After
being equilibrated at ambient temperature for 24 hours, the
mixtures were assessed visually and determined as being
MEs, crude emulsions, or ME gels. The stable MEs were also
observed under polarizing light to conform their isotropic
nature. No attempt was made to distinguish between oil-
in-water, water-in-oil, or bicontinuous type MEs. Gels were
claimed for those clear and highly viscous mixtures that did
not show a change in the meniscus after being tilted to an
angle of 90◦.
ME formulation was selected from the pseudoternary
phase diagram with 3:1 weight ratio of caprylocaproyl
macrogol-8-glyceride to polyglyceryl oleate. ITN was added
to the mixtures of oil and S/CoS, and then an appropriate
amount of distilled water was added to the mixture drop by
drop and the ME containing ITN was obtained by stirring
the mixtures at ambient temperature which was stored at
ambient temperature. Table 1 shows composition of selected
ME formulation.ISRN Pharmaceutics 3
Table 1: Composition of selected microemulsions (%w/w).
Components Content
Isotretinoin 0.5%w/w
Isopropyl myristate 4.0%wt/wt
Caprylocaproyl macrogol-8-glyceride 31.5%wt/wt
Polyglyceryl oleate 10.5%wt/wt
Aqueous phase q. s. for 100%wt/wt
2.6. Characterization of ITN-Loaded Microemulsion. The
average droplet size and polydispersity index of ME was
measured by photon correlation spectroscopy (PCS) with
in-built Zetasizer (Nano ZS, Malvern Instruments, UK) at
633nm. Helium neon gas laser having intensity of 4mW,
was the light source. The droplet size was calculated using
Stokes—Einstein relationship by Zetasizer Software. Trans-
missionelectronmicroscopy(TEM)wasusedtocharacterize
the microstructure of ITN loaded ME. ME was placed
on a carbon-coated copper grid and then a drop of 1%
phosphotungstic acid covered on MEs. The superﬂuous
phosphotungstic acid on MEs was wiped oﬀ by ﬁlter paper.
The TEM images were obtained using a Tecnai G2 20TEM
(Philips, Holland). The refractive index of the system was
measuredbyanAbberefractometer(BauschandLombOpti-
cal Company, Rochester, NY) by placing 1 drop of solution
on the slide. The percent transmittance of the system was
measured using a colorimeter (Digital Colorimeter, D-801,
Photocon) at 570–590nm. In order to verify the isotropic
nature of ME, samples were examined using cross-polarized
light microscopy (Polarizing Microscope, Carlzeless, Jena,
Germany). A drop of sample was placed between a cover slip
and a glass slide and then observed under cross-polarized
light. The pH values of ME was determined using digital pH
meter (Orion pH meter 420A, Allometric Ltd., Baton Rouge,
LA), standardized using pH 4 and 7 buﬀers before use. The
viscosity of ME was measured using a Brookﬁeld Viscometer
(BrookﬁeldEngineeringLABS,Stoughton,MA)withspindle
LV-III at 100rpm using interval of 30 seconds. All aspects
of testing were controlled using optional Rheocalc Software.
The electric conductivity of ME was measured with a
conductivitymeter(Equip-Tronics,EQ-664,Mumbai,India)
equipped with in-built magnetic stirrer. This was done by
using conductivity cell (with a cell constant of 1.0) consisting
oftwoplatinumplatesseparatedbydesireddistanceandhav-
ing liquid between the platinum plate acting as a conductor
[12, 13].
2.7. Photostability Study of ITN in Solution. The photo-
stability of ITN [24, 25] was assessed by recording its
absorption spectra over the wavelength range of 200–500nm
in two matched quartz cells with a 1cm light path using a
double beam UV-Visible spectrophotometer (Perkin Elmer,
Lambda 19, Norwalk, CT) at the following conditions:
scan speed-slow; time response 1s; spectral band 1nm.
The radiant power was adjusted to the lower value in the
instrumental scale, and the cabinet temperature at 25◦C.
These gentle experimental conditions were set because of the
high sensitivity of the drug to light, allowing so to obtain
200nm
Figure 1: The TEM image of isotretinoin loaded microemulsion
containing isopropyl myristate as an oil phase.
more accurate control of the photodegradation process.
Methanolic solution of ITN (concentration: 20µg/mL) was
exposed to natural sunlight (>20,000 Lux) and the UV
spectra of the samples were recorded just after preparation
(t = 0)andatthefollowingtimeintervals:15,30,60,90,120,
150,180,210,240min,aftersuitabledilutionwithmethanol.
All sample solutions were ﬁltered through nylon 0.45µm
membrane ﬁlters.
2.8. Phototstability Study of ITN in Microemulsion. ME for-
mulation was exposed to light under the same experimental
conditions described above for solution, and recording the
spectra at the same irradiation times. For ME formulation,
spectrophotometricmeasurementwasperformedbydiluting
itsuitablywithmethanol.Baselinecorrectionwasdoneusing
a plain ME dispersion diluted suitably with methanol to
nullify any possible absorption arising from the excipients.
All sample solutions were ﬁltered through nylon 0.45µm
membrane ﬁlters.
Suﬃcient care was taken to maintain similar experi-
mental conditions for both the samples, that is, ITN in
methanol and ITN in ME. Consequently, an interpretation
of the photodegradation process of ITN by determination of
kinetic parameters was tried as a complementary aim of the
photostability study.
3. Results and Discussion
Particle size of plain ME and drug-loaded ME were deter-
mined, and there was no signiﬁcant diﬀerence observed
in average particle size after loading the drug. The ME
formulation had the lowest average particle size 45 ± 0.5nm
with polydispersity index (PI) of 0.145 ± 0.027. PI is a
measureofparticlehomogeneityanditvariesfrom0.0to1.0.
The closer to zero the PI value the more homogenous are the
particles. The PI showed that ME formulation had narrow
size distribution. The TEM imaging of ITN loaded MEs is
shown in Figure 1. The particle size of ITN loaded MEs from
TEM images (Figure 1) accords with that of from PCS. The
imaging showed that ITN loaded ME exhibited a spherical
shape and had a narrow size distribution. The refractive
index of the developed ME was found to be 1.329 and
percent transmittance >99% which proved the transparency
ofthesystem.Thesamplewasexaminedbyocularinspection4 ISRN Pharmaceutics
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Figure 2: Overlaid UV spectra of 20µg/mL ITN in methanol
solution and 25µg/mL ITN in microemulsion.
Table 2: Regression analysis of calibration curve for isotretinoin
(ITN) by the proposed UV spectrophotometric method (n = 5).
Parameters ITN
Concentration range 5–40µg/mL
Slope 0.1115
Standard deviation of the slope 0.57 ×10
−4
Intercept −0.1045
Standard deviation of the intercept 0.48 ×10
−3
Correlation coeﬃcient 0.9998
in a cross polarizer for sample homogeneity and birefrin-
gence. The ME appeared completely dark when observed
under cross polarizer which indicated that it was optically
isotropic. The ME formulation had appropriate observed
pH value (5.9 ± 0.24) for topical application. Incorporation
of ITN did not signiﬁcantly aﬀect the observed pH value
of the ME formulations. The developed system had the
low viscosity (31.54 ± 0.23mPa·s) and high conductivity
(149.5 ± 2.21µS/cm). There was no signiﬁcant diﬀerence
found between the viscosities of plain and drug-loaded
MEs. The investigated ME formulation containing nonionic
surfactant mixture, oil, and water showed electroconductive
behaviour in spite of its non-ionic nature. From the viscosity
and electroconductive study it could be concluded the
prepared ME formulation was of o/w type [12, 13].
3.1. UV Spectra of ITN. Figure 2 shows the UV spectra of
ITN in methanol solutions. As evident, ITN is characterized
by the presence of one imposing absorbance maximum at
348nm. Calibration graphs were obtained by applying least
squares regression analysis to the absorbance amplitudes at
the single-maximum peaks against the increasing concen-
trations of pure ITN. The calibration curves parameters are
summarized in Table 2.
3.2. Photostability of ITN in Solution. The spectral curves
recorded on the methanolic solution of ITN at the various
times of light exposure are shown in Figure 3. The light
exposure caused a sharp degradation after 15 minutes of
irradiation with a contemporary shift of maximum peak
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Figure 3: UV spectra of a 20µg/mL ITN in methanol solution after
diﬀerent times of light exposure.
from348to342nmindicatingtheisomerizationofITNto9-
cis isomer [25]. A slower degradation was observed later on
with the minimization of the 337nm maximum peak with
a 50% absorbance lowering, compared to the initial value.
Further light exposure caused the minimization of this peak
with its simultaneous shift to lower wavelengths, probably
due to a complex mixture of several retinoic acid isomers.
Such results point out the very high sensitivity to light of
ITN, suggesting the importance of the development of a
pharmaceutical carrier able to minimize its photodegrada-
tion. Recent studies have demonstrated the positive action of
the novel formulation matrix as carrier systems for a number
of photosensitive drugs [19–25]. The ﬁrst goal of the present
study was to investigate the photostabilization of the ITN
when loaded in ME through data obtained under conditions
of accelerated irradiation. Consequently, an interpretation of
the photodegradation process of ITN drug was tried as a
complementary study.
3.3.PhotostabilityofITNinMicroemulsion. Thephotostabil-
ity studies were carried out by spectrophotometric measure-
ments performed on the ITN loaded ME formulation just
before exposure and exposure at increasing times by diluting
the samples suitably with methanol. Figure 4 shows the
spectral curves of the ITN loaded ME formulation obtained
after the sequential exposure times. As can be seen, the
I T Ni nM Ec a r r i e r ,s t r o n g l yr e d u c e dt h ep h o t o d e g r a d a t i o n
process as compared to that of the methanolic solution.
On the other hand, the photostability of the ITN in ME
formulation improved as compared to that recorded of the
methanolic solution. Furthermore, signiﬁcant shift of the
maximum peak at 348nm to lower wavelength was not
observed. This may be considered as an interesting result,
as it demonstrates no direct isomerization of ITN to 9-cis
isomers [25]. Also, a residual ITN concentration of 75%
was still present after irradiation for and 240min which was
signiﬁcantly higher in comparison to ITN concentration in
methanolic solution at the end of 240min (P<0.05). The
dramatic improvement in the photostability of ITN indicates
positive action of the ME matrix as a carrier system.ISRN Pharmaceutics 5
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Figure 4: UV spectra of a 25µg/mL ITN in microemulsion after
diﬀe r e n tt i m e so fl i g h te x p o s u r e .
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Figure 5: Photodegradation plots of ITN solution in methanol ()
and microemulsion containing ITN (). All values are means of
three replicated experiments.
In order to evaluate photostability of ME excipients,
a parallel analytical control on the formulation matrix
photostability was also performed. For this purpose, sample
of plain ME was irradiated under the same experimental
conditions adopted for the ITN loaded ME. No appreciable
changes between the spectra recorded before and after
light exposure were detected, clearly showing that any
photodegradation occurring during experimental time was
negligible.
Ioele et al. reported that the inclusion of ITN in
liposomes did not give satisfactory results and shows higher
degradation rate than the retinoic acid in liposomes complex
studied, but showing an increased stability if compared with
the ITN in ethanol solution and concluded that ITN in
liposomes showed a worse performance among the drugs
Table 3: Rate constants∗ of photodegradation for ITN in methanol
solution and microemulsion (n = 3).
Drug Sample matrix K t0.5 R2
ITN
Methanol solution 8.06 ×10
−3 86 0.9830
Microemulsion 1.84 ×10
−3 377 0.9899
formulation
∗t is expressed in minutes.
studied, probably due to a low inclusion as a result of non-
linear molecular structure [25]. In current study, a residual
ITN concentration of 75% was found to be present after
irradiation for 240min in ME. On the contrary, in previous
study [25] the inclusion of ITN in liposomes did not give
analogous satisfactory results, residual ITN concentration
was less than 65%.
In a nutshell, we can conclude that ME exhibits a good
potential to improve the photostability of ITN and can be
employed as a valuable drug delivery strategy.
3.4. Kinetic Parameters Determination. The photochemical
reaction in methanol solution was demonstrated to cause a
very rapid isomerization of ITN followed by a further degra-
dation consisting in the minimization of the absorbance
peaks. Therefore, the absorbance values of these maxima
were used to evaluate the kinetics of the photodegradation
processes [25]. ITN was shown to follow a ﬁrst order kinetics
and a good linearity was obtained by plotting the logarithm
of absorbances as a function of time, both in methanolic
solution and in ME, in accordance with the following
equation:
log (%A) =− kt +2 (1 )
where, %A was percent residual absorbance, k was the
photodegradation rate constant, t was the time (min), and
2 was the logarithm of initial percent absorbance (100%).
The degradation was evaluated on the basis of kinetic
photodegradation constant k and half-life time (t0.5), with
respect to the initial percent absorbance. ITN degradation
curves are plotted in Figure 5 while Table 3 summarizes the
degradation kinetic parameters based on data from three
replicate analyses for each sample. ME demonstrated to
increase ITN half-life about ﬁve-times in comparison with
a methanol solution, under a direct sun light.
4. Conclusion
As it is evident, the ITN inclusion in ME results in a
good photostability of the drug, whereas in methanol ITN
degraded almost completely after about 240min under a
direct sun light, while in the ME matrix still 75% of residual
ITN concentration could be measured. Results obtained
from this photostability study lead us to suppose that
the better photoprotection of ITN in ME matrix is the
consequence of the inclusion of this drug in ME matrix.
Further, studied kinetics of the photodegradation processes
for ITN loaded ME formulation demonstrated to increase6 ISRN Pharmaceutics
ITNhalf-lifeaboutﬁve-timesincomparisonwithamethanol
solution, under a direct sun light.
The ME system described in the present paper should
provide a valuable tool for the development of new phar-
maceutical formulations of ITN, capable of improving their
photostability.
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